There are more than 30 genes for putative multidrug efflux pumps in the chromosome of Staphylococcus aureus. Only a few of these have been analyzed so far. Here we cloned a new gene, SA1972, using a PCR method, from the chromosome of S. aureus N315. We found that the product SA1972 could lead to elevated resistance against several antimicrobial agents such as norfloxacin, acriflavine and ethidium bromide. We designated the gene as sdrM. We observed elevated energy-dependent efflux of acriflavine in S. aureus cells introduced with the sdrM gene. We conclude that SdrM is a multidrug efflux pump belonging to the major facilitator (MF) superfamily.
Antimicrobial agents are used to treat patients infected with bacteria. However, treatment of such patients by antimicrobial agents often produces drug resistant bacteria. Multidrug resistant bacteria have emerged after use of multiple antimicrobial agents, and have spread all over the world. Infections with multidrug resistant bacteria are serious clinical problems nowadays. Patients infected with multidrug resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) are difficult to treat because only a few antimicrobial agents are effective on such multidrug resistant bacteria. MRSA easily infect immuno-compromised hosts. Thus, the frequency of infection with MRSA is very high among nosocomial infections. 1) Several mechanisms of drug resistance are known in bacteria; 1) inactivation of the drug by degradation-or modification-enzymes, 2) alteration of the drug target, 3) emergence of a bypass pathway which is not inhibited by the drug, 4) reduced membrane permeability for the drug, and 5) drug efflux, especially multidrug efflux, from cells. Among these mechanisms, multidrug efflux is most profoundly involved in multidrug resistance in bacteria. Multidrug efflux pumps extrude multiple toxic compounds from cells. Thus, multidrug efflux pumps are very important for bacterial escape from toxic compounds. MRSA is resistant not only against methicillin but also against most antimicrobial agents. This suggests that there would be many and effective multidrug efflux pumps in the cells of MRSA. Judging from the genome sequence information of S. aureus N315, 2) it seems that more than 30 genes or operons for putative multidrug efflux pumps that are present in the chromosome. Five multidrug efflux pumps encoded by the chromosome of S. aureus have been reported so far, NorA, [3] [4] [5] [6] MdeA, 7) NorB, 8) MepA, 9, 10) SepA. 11) There are many hitherto uncharacterized multidrug efflux pumps in S. aureus. Here we report the gene cloning and properties of a new multidrug efflux pump from S. aureus N315, an MRSA strain.
MATERIALS AND METHODS
Bacteria and Growth S. aureus N315 (MRSA strain) with which the genome project has been completed 2) was used as a source of chromosomal DNA. Escherichia coli strain KAM32, a drug-hypersusceptible strain due to the lack of major multidrug efflux pumps, 12) and S. aureus RDN1, a drug-susceptible strain due to the lack of the NorA multidrug efflux pump 13) were used as hosts for gene manipulation. S. aureus cells were grown in nutrient broth (Nissuiseiyaku Inc.), and E. coli cells were grown in L medium (1% polypeptone, 0.5% sodium chloride, 0.5% yeast extract), under aerobic conditions at 37°C. The growth of cells was monitored turbidimetrically at 650 nm.
DNA Manipulations
We cloned SA1972 as follows: a DNA fragment containing the SA1972 gene was amplified by the PCR method using chromosomal DNA of S. aureus N315 as template with the primers, ATATGCGATTAAAGTCAAT-CATAACTGT (forward) and CGCGGATCCATTATATGTA AAGTCACCCAACCTAAA (reverse), both of which generate flanking BamHI sites. The amplified DNA fragment containing the SA1972 gene was digested with BamHI and then ligated into the corresponding sites of a vector pRIT5H derived from pRIT5, 14) a shuttle vector between E. coli and S. aureus, to generate pRMF1972. The promoter for the spa gene, a gene for protein A of S. aureus, the Shine-Dalgarno sequence 15) and an initiation ATG both for the norA gene proceeded the SA1972 gene in the pRMF1972 plasmid. For propagation, the recombinant plasmids were introduced into competent cells of E. coli.
16) The pRMF1972 plasmid was introduced into cells of S. aureus RDN1 by electroporation 17) with Gene Pulsar (BioLad Inc.). We obtained three independent clones of S. aureus RDN1/pRMF1972 starting from three independent PCR experiments. The three clones showed very similar results. Thus, we show here the result of one clone.
Drug Susceptibility Testing The minimum inhibitory concentrations (MICs) of various drugs were determined in Mueller-Hinton (MH) broth (Difco) containing different drugs at various concentrations by using the two-fold dilution method.
18) Cells were incubated in the test medium at 37°C
for 24 h, and the growth was judged by visual inspection. Acriflavine Transport in S. aureus Cells were grown in nutrient broth containing chloramphenicol (10 mg/ml). The cells were harvested and washed with ice-cold nutrient broth, and then re-suspended in nutrient broth to a final optical density of 0.4 at 650 nm. The cell suspension was used as an assay mixture and incubated at 37°C, and glucose (final concentration, 10 mM) was added to the assay mixture. The fluorescence of the assay mixture was measured (excitation at 448 nm; emission at 504 nm) continuously. Acriflavine (final concentration, 2.5 mM) was added to the assay mixture to initiate the assay, and carbonyl cyanide m-chlorophenylhydrazone (CCCP) (final concentration, 100 mM) was added to assess the effect of the energy inhibitor, as reported previously.
12)
Reverse Transcription (RT)-PCR Cells of S. aureus N315 were harvested at the exponential phase of growth. Total cellular RNA was isolated from the cells using the Qiagen RNeasy Mini Kit (Qiagen Inc., U.S.A.), treated with RNase-free DNase (Promega, U.S.A.) (1 U of enzyme/mg RNA for 2 h at 37°C) and re-purified using the same kit. 19 ) A 1 ng sample of DNase-treated RNA was used as a template for RT-PCR with the Qiagen OneStep RT-PCR Kit (Qiagen) according to the manufacturer's protocol. Primer pairs specific for and internal to both sdrM and the rpsL genes (encoding a constitutively expressed ribosomal protein that was used as a control) were used for RT-PCR. Primers used for sdrM were: CGCGTGATACAAGGTTTTGG (forward) and AAGCGGTCCAATGATACTCG (reverse); and for rpsL: CACCACAAAAACGTGGTGTATG (forward) and TGTTG-TTTGATAAACGCACACG (reverse) primers were used. A 5 ml sample of each reaction product was analyzed by Agarose X (3% w/v) (Wako Pure Chemicals) gel electrophoresis for presence of the expected RT-PCR products.
RESULTS AND DISCUSSION
Gene Cloning and Activity We found more than 30 genes or operons for putative multidrug efflux pumps in the genome of S. aureus N315 (http://www.bio.nite.go.jp/dogan/ MicroTop?GENOME_IDϭn315G1). We have been trying to clone many of them. We found one gene SA1972, the product of which (SA1972) showed sequence similarity with several proteins that function as multidrug efflux pumps in S. aureus, such as NorB 8) and QacA. 20) Identity and similarity in the amino acid sequence of SA1972 with NorB were 23% and 68%, respectively, and with QacA were 21% and 65%, respectively. It seemed that SA1972 possessed 14 trans-membrane domains because there were 14 hydrophobic regions with proper length in the deduced primary structure. As judged from the sequence similarities, it seemed that the SA1972 protein belonged to the major facilitator (MF) superfamily of transporters. 21) Recombinant plasmid pRMF1972 carrying the SA1972 gene was introduced into cells of S. aureus RDN1, a strain lacking the NorA multidrug efflux pump and susceptible to several antimicrobial agents, [3] [4] [5] [6] and changes in drug susceptibility was tested. We measured the MIC values of 24 antimicrobial agents with S. aureus RDN1/pRIT5H (control) and S. aureus RDN1/pRMF1972 (carrying the SA1972 gene) ( Table 1) . Among the 24 agents, we observed elevated MICs of norfloxacin, acriflavine and ethidium bromide with RDN1/pRMF1972 compared with RDN1/pRIT5H. Although the increases of the MICs of norfloxacin and ethidium bromide were 2-fold, they were reproducible. Thus, we conclude that SA1972 is responsible for multidrug resistance. We designated SA1972 as the sdrM (Staphylococcus drug resistance) gene.
We cloned the sdrM (SA1972) gene by the PCR method. Mistake(s) in PCR may occur, and may produce a DNA fragment with a little different sequence from the original SA1972 gene. We obtained three independent clones as mentioned in the Materials and Methods, and they showed very similar results. Thus, we believe that sdrM is really a multidrug efflux pump, belonging to the MF superfamily.
Drug Efflux Activity We measured drug efflux activity. Ethidium bromide is often used as a substrate for drug efflux pumps. Although ethidium is a substrate for SdrM, it is not a good substrate judging from the change in the MIC of ethidium bromide (Table 1) . On the other hand, acriflavine seems to be a good substrate for SdrM (Table 1) . Therefore we used acriflavine as a substrate to measure the drug efflux activity of SdrM. We observed a lower intracellular level of acriflavine with cells of S. aureus RDN1/pRMF1972 (carrying sdrM) compared with cells of RDN1/pRIT5H (control) (Fig. 1) . After the addition of an H ϩ conductor CCCP, which dissipates an electrochemical potential of H ϩ across the cytoplasmic membrane, a driving force for the MF superfamily of transporters, acriflavine reached the same intracellular lev- Cells of S. aureus were incubated in the assay medium. Glucose (final concentration, 10 mM) was added to energize the cells, and then acriflavine (final concentration, 2.5 mM) was added at the time point indicated by the first downward arrow to initiate the assay. CCCP (final concentration, 100 mM) was added to the assay mixture as an energy inhibitor at the time point indicated by the second downward arrow. A decrease in fluorescence intensity indicates accumulation of acriflavine in cells. Curve A, S. aureus RDN1/pRIT5H (control); curve B, S. aureus RDN1/pRMF1972 (carrying sdrM). els in the two types of cells. It should be pointed out that fluorescence of acriflavine decreases upon binding to DNA in cells. 12) These results support the idea that SdrM is an energy-dependent drug efflux pump.
Expression of sdrM We investigated expression of the sdrM gene in cells of S. aureus N315 by the RT-PCR method. However, we could not detect a corresponding band representing expression of the sdrM gene although we had detected a band corresponding to a house-keeping gene rpsL (data not shown). Thus, we conclude that the sdrM gene is not well expressed constitutively in S. aureus N315. However, mutation in the sdrM operon may lead to emergence of more resistant S. aureus mutants. We found a nucleotide sequence TTAATT in the upstream region (89 base-pairs upstream) from the putative promoter for the sdrM gene. It has been reported that this sequence is one of the binding sites for MgrA, a regulatory protein for the norB gene. 8) Therefore it is likely that the MgrA protein also regulates the expression of the sdrM gene. Mutation in the mgrA region may lead to enhanced expression of the sdrM and norB genes, and to the emergence of a more resistant mutant.
